Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 6, 2021 (5 years ago)

Phenol

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Phenol, Sterile Solution for Injection (PF), 6%, 5 mL per vial, Single Use Vial for Perineural Injection, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1476-05, packaged in vials.

Affected NDC 5446-1476-05

Compare with the code on your package — it is the most precise check available.

Drug: Phenol

Recalling firm
Edge Pharma, LLC
NDC code
05446-1476-05
Origin
VT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0413-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Phenol recalls

See all
Class II · Moderate risk

Unguentine Ointment

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Completed cGMP deviation Ecometics, Inc. D-1099-2023
Class II · Moderate risk

Phenol 10%

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Terminated Sterility / contamination Pharmacy Innovations D-0229-2023
Class II · Moderate risk

Phenol

CGMP Deviations

Terminated cGMP deviation Edge Pharma, LLC NDC 05446-1211-03 D-0443-2022

Other recalls by Edge Pharma, LLC

All 2021 recalls